Related Experiment Videos
Temporal lobectomy in patients with bitemporal epilepsy defined by depth electroencephalography
L J Hirsch1, S S Spencer, D D Spencer
1Department of Neurology, Yale University School of Medicine, New Haven, CT.
Annals of Neurology
|September 1, 1991
Summary
Temporal lobectomy is effective for epilepsy treatment. Even if less than 80% of seizures originate from one temporal lobe, it may still be a viable surgical option for patients with refractory epilepsy.
Area of Science:
- Neurosurgery
- Epileptology
- Clinical Neurology
Background:
- Temporal lobectomy is a common surgical treatment for refractory epilepsy.
- Patient selection is crucial for successful surgical outcomes.
- The precise percentage of seizures originating from the target lobe is a key consideration.
Purpose of the Study:
- To evaluate the efficacy of temporal lobectomy in patients with seizures originating independently from each temporal lobe.
- To determine if a lower percentage of seizures originating from the target lobe impacts surgical outcomes.
- To reassess the criteria for patient selection for temporal lobectomy.
Main Methods:
- Review of 23 patients with bilateral independent temporal lobe seizures identified by depth electroencephalography (EEG).
- Assessment of neuropsychological testing, interictal EEG, imaging, and subclinical seizures.
- Analysis of outcomes for 11 patients who underwent temporal lobectomy, considering seizure origin percentage.
Main Results:
- All 11 patients who underwent temporal lobectomy achieved significant seizure reduction.
- Nine patients became seizure-free, one had >75% reduction, and one had 50-75% reduction.
- Outcomes were similar between patients with <80% and ≥80% of seizures originating from the resected lobe.
Conclusions:
- Having fewer than 80% of seizures originate from one temporal lobe should not be an absolute contraindication for temporal lobectomy.
- Depth EEG is valuable in identifying independent temporal lobe seizure origins.
- Temporal lobectomy remains an effective treatment for selected patients with bilateral independent temporal lobe epilepsy.